Remote Jobs at Pulmovant
Find your next remote opportunity · 2 Open Positions
Pulmovant is a clinical-stage biotechnology company developing innovative therapies for patients suffering from pulmonary diseases.
Pulmovant’s first program, mosliciguat is designed to provide an effective, once-daily, inhaled treatment option for patients with pulmonary hypertension (PH).
Mosliciguat is a novel, potential first-in-class, sGC activator with a differentiated mechanism that may have broad applicability across the PH spectrum.
Senior Director, Regulatory Affairs
Senior Regulatory Affairs leader guiding Pulmovant’s mosliciguat, an inhaled pulmonary hypertension therapy, through global clinical development and approval. Shaping FDA and international submission strategy.
Director, Biostatistics
Director of Biostatistics leading statistical strategy for Pulmovant’s Phase 3 PH-ILD trial. Driving regulatory-ready analyses for its inhaled mosliciguat treatment.
No more jobs available.